美股詳情

本頁面由Tiger Trade Technology Pte. Ltd.提供服務

iShares Neuroscience and Healthcare ETF

39.53

-0.1185-0.30%

盤後：39.530.00000.00%16:10 EDT

成交量：982

成交額：3.86萬

市值：790.59萬

市盈率：- -

高：39.53

開：39.11

低：39.11

收：39.65

52周最高：43.01

52周最低：24.58

股本：20.00萬

流通股本：20.00萬

量比：0.50

換手率：0.49%

股息：0.32

股息率：0.81%

淨資產收益率：--

總資產收益率：--

市淨率：--

市盈率(LYR):- -

資料載入中...

總覽公司新聞資訊公告

首批基金2026年中期報告出爐看好有色、腦機接口等方向

《柳葉刀·神經病學》刊發阿爾凱默斯Alixorexton治療1型發作性睡病II期臨床積極數據

腦機接口保險，從定製到普惠還有多遠

工信部就《國家腦機接口產業標準體系建設指南》公開徵求意見。

通化金馬與宣武醫院簽署戰略合作推進阿爾茨海默病新藥臨床與腦卒中管線佈局

聯影醫療與天津大學發布全球首個磁共振腦機接口全棧式解決方案

算力腦機接口接連入局鐵路「跨界」新玩法探路數智化轉型

中国经营报

全國首屆磁共振腦機接口大會在津舉辦

聯影、天津大學聯合發布全球首個磁共振腦機接口全棧式解決方案uMR神觀

聯影、天津大學聯合發布全球首個磁共振腦機接口全棧式解決方案uMR神觀

Neko Health 與 Neuralink 合作篩選試驗受試者

市場消息：Spotify 首席執行官埃克表示，Neko Health 正與腦機接口公司 Neuralink 開展合作。

Scholar Rock撤回了針對肌肉無力藥物的歐洲申報，計劃重新提交

福瑞醫科(300049.SZ)：公司暫無腦機接口的研究

Scholar Rock控股公司獲日本PMDA認可，無需補充臨床研究；計劃2026年底提交Apitegromab上市申請

Scholar Rock Holding公司撤回歐洲上市申請，計劃以替代灌裝生產線重新提交

Scholar Rock Holding Corp：蓄勢待發，靜候FDA批准，Apitegromab擬於2026年9月30日PDUFA日期登陸美國市場

深圳落地腦機接口數據知識產權登記

佔國內近30%！閔行這裏憑什麼吸引企業和人才？

山西首例侵入式腦機接口植入術完成截癱患者有望重塑運動功能

{"basename":"/hant","ssrTDKData":{"titleTemplate":"%s - 老虎證券","title":"老虎证券全球投资理财平台| 一站式投资美股新股港股A股","description":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","keywords":"老虎證券,老虎證券開戶,老虎券商,老虎證券官網,老虎證券app,tigertrade老虎證券,股票,炒股,新加坡股票交易平臺,投資,投資理財","social":{"ogDescription":"老虎证券助您一站式投资美股，新股，港股，A股等全球金融理财产品。新加坡华人最信赖的在线投资平台，现在加入即享低费用，24/5 无时差炒美股投资理财！","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.0a0bd8dc.png","ogUrl":"https://www.itiger.com/hant/stock/IBRN/news"},"companyName":"老虎證券"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"IBRN","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","market":"US","secType":"STK","nameCN":"iShares Neuroscience and Healthcare ETF","latestPrice":39.5297,"timestamp":1787601600000,"preClose":39.6482,"halted":0,"volume":982,"hourTrading":{"tag":"盘后","latestPrice":39.5297,"preClose":39.5297,"latestTime":"16:10 EDT","volume":6,"amount":237.1782,"timestamp":1787602204719,"change":0,"changeRate":0,"amplitude":0},"delay":0,"changeRate":-0.002988786376178603,"floatShares":200000,"shares":200000,"eps":0,"marketStatus":"盤後交易","change":-0.1185,"latestTime":"08-24 19:55:28 EDT","open":39.11,"high":39.5297,"low":39.11,"amount":38594,"amplitude":0.010586,"askPrice":59.11,"askSize":200,"bidPrice":37.05,"bidSize":1,"shortable":3,"etf":1,"ttmEps":0,"tradingStatus":3,"nextMarketStatus":{"tag":"收盤","tradingStatus":0,"beginTime":1787616000000},"marketStatusCode":4,"adr":0,"exchange":"ARCA","adjPreClose":39.6482,"sharesOutstanding":150000,"nav":39.601587,"aum":7920317.4,"dividendRate":0.008123,"bidAskSpread":0,"preHourTrading":{"tag":"盘前","latestPrice":39.64,"preClose":39.6482,"latestTime":"09:29 EDT","volume":1,"amount":39.64,"timestamp":1787578185971,"change":-0.0082,"changeRate":-0.000207,"amplitude":0},"postHourTrading":{"tag":"盘后","latestPrice":39.5297,"preClose":39.5297,"latestTime":"16:10 EDT","volume":6,"amount":237.1782,"timestamp":1787602204719,"change":0,"changeRate":0,"amplitude":0},"volumeRatio":0.496562,"impliedVol":0.0464,"impliedVolPercentile":0.0717},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"IBRN\",,,,,undefined,":{"symbol":"IBRN","floatShares":200000,"roa":"--","roe":"--","lyrEps":0,"volumeRatio":0.496562,"shares":200000,"dividePrice":0.3211,"high":39.5297,"amplitude":0.010586,"preClose":39.6482,"low":39.11,"week52Low":24.5795,"pbRate":"--","week52High":43.01,"institutionHeld":0,"latestPrice":39.5297,"committee":-0.99005,"eps":0,"divideRate":0.008123,"volume":982,"delay":0,"ttmEps":0,"open":39.11,"prevYearClose":32.3193,"prevWeekClose":39.6482,"prevMonthClose":36.6044,"prevQuarterClose":38.8263,"fiveDayClose":39.6414,"twentyDayClose":37.7182,"sixtyDayClose":35.6957},"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/IBRN\",params:#limit:5,,,undefined,":[{"date":"2025-12-16","symbol":"IBRN","amount":0.319807,"announcedDate":"2025-12-15","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2025-12-16","defaultRemindTime":1765895400000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2025-12-19","payableDate":"2025-12-16","currency":"USD","dateTimestamp":1765861200000,"payDate":"2025-12-19"},{"date":"2024-12-17","symbol":"IBRN","amount":0.10114,"announcedDate":"2024-12-16","type":"dividend","lastAmount":null,"market":"US","newRecordDate":"2024-12-17","defaultRemindTime":1734445800000,"name":"iShares Neuroscience and Healthcare ETF","lastCurrency":null,"lastExecuteDate":null,"recordDate":"2024-12-20","payableDate":"2024-12-17","currency":"USD","dateTimestamp":1734411600000,"payDate":"2024-12-20"},{"date":"2023-12-20","symbol":"IBRN","amount":0.006303,"announcedDate":"2023-12-19","type":"dividend","market":"US","newRecordDate":"2023-12-21","defaultRemindTime":1703082600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-12-27","payableDate":"2023-12-21","currency":"USD","dateTimestamp":1703048400000,"payDate":"2023-12-27"},{"date":"2023-06-07","symbol":"IBRN","amount":0.008241,"announcedDate":"2023-05-12","type":"dividend","market":"US","newRecordDate":"2023-06-08","defaultRemindTime":1686144600000,"name":"iShares Neuroscience and Healthcare ETF","recordDate":"2023-06-13","payableDate":"2023-06-08","currency":"USD","dateTimestamp":1686110400000,"payDate":"2023-06-13"}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"IBRN\",market:\"US\",,,undefined,":[{"executeDate":"2023-06-07","recordDate":"2023-06-08","paymentDate":"2023-06-13","value":0.008241,"currency":"USD"},{"executeDate":"2023-12-20","recordDate":"2023-12-21","paymentDate":"2023-12-27","value":0.006303,"currency":"USD"},{"executeDate":"2024-12-17","recordDate":"2024-12-17","paymentDate":"2024-12-20","value":0.10114,"currency":"USD"},{"executeDate":"2025-12-16","recordDate":"2025-12-16","paymentDate":"2025-12-19","value":0.319807,"currency":"USD"}],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"IBRN\",market:\"US\",delay:false,,,undefined,":{},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"IBRN\",pageSize:20,pageCount:1,lang_content:\"cn\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2662043952","title":"首批基金2026年中期報告出爐 看好有色、腦機接口等方向","url":"https://stock-news.laohu8.com/highlight/detail?id=2662043952","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2662043952?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 07:23","pubTimestamp":1787613806,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1141245521","title":"《柳葉刀·神經病學》刊發阿爾凱默斯Alixorexton治療1型發作性睡病II期臨床積極數據","url":"https://stock-news.laohu8.com/highlight/detail?id=1141245521","media":"美股速递","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1141245521?lang=zh_tw&edition=fundamental","pubTime":"2026-08-25 06:31","pubTimestamp":1787610670,"startTime":"0","endTime":"0","summary":"《柳叶刀·神经病学》杂志近日正式发表了阿尔凯默斯旗下在研药物Alixorexton的Vibrance-1 II期临床研究数据。该研究聚焦于成年1型发作性睡病患者，结果令人振奋。这项研究结果在顶级医学期刊上的亮相，标志着阿尔凯默斯在睡眠障碍治疗领域迈出了坚实一步。Alixorexton作为一种新型治疗手段，其临床数据经过了严格的同行评审，最终获得权威刊物的认可。阿尔凯默斯公司表示，这些积极数据将进一步推动Alixorexton的研发进程，有望为患者带来新的治疗选择。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["PSCH","BK4139","PSIL","IBRN","MEDX","FBT","ALKS"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661276208","title":"腦機接口保險，從定製到普惠還有多遠","url":"https://stock-news.laohu8.com/highlight/detail?id=2661276208","media":"第一财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661276208?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 20:20","pubTimestamp":1787574000,"startTime":"0","endTime":"0","summary":"从产品属性看，本次脑机接口手术意外险属于面向特定医疗机构、特定术式路径、合规上市植入设备的定向定制方案，并非可以面向全国市场批量投放、通用适配的标准化险种。当手术进入常规临床应用阶段，患者将成为最终付费主体，保费以手术意外险形式纳入整体治疗费用，与当前骨科、心外科手术意外险模式趋同。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/roll/2026-08-24/doc-inipmnpm0046366.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/roll/2026-08-24/doc-inipmnpm0046366.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661949275","title":"工信部就《國家腦機接口產業標準體系建設指南》公開徵求意見。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661949275","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661949275?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 19:43","pubTimestamp":1787571800,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661822276","title":"通化金馬與宣武醫院簽署戰略合作 推進阿爾茨海默病新藥臨床與腦卒中管線佈局","url":"https://stock-news.laohu8.com/highlight/detail?id=2661822276","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661822276?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 17:39","pubTimestamp":1787564370,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661228681","title":"聯影醫療與天津大學發布全球首個磁共振腦機接口全棧式解決方案","url":"https://stock-news.laohu8.com/highlight/detail?id=2661228681","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661228681?lang=zh_tw&edition=fundamental","pubTime":"2026-08-24 12:53","pubTimestamp":1787547215,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661131243","title":"算力腦機接口接連入局 鐵路「跨界」新玩法探路數智化轉型","url":"https://stock-news.laohu8.com/highlight/detail?id=2661131243","media":"中国经营报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661131243?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 22:56","pubTimestamp":1787497016,"startTime":"0","endTime":"0","summary":"8月下旬，两桩来自铁路体系的跨界合作接连落地。8月18日，山东铁路发展基金有限公司（以下简称“山东铁路基金”）与北京硅基流动科技股份有限公司（以下简称“硅基流动”）签署战略合作协议，着手共建“Token工厂”。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"stock_eastmoney","url":"http://finance.eastmoney.com/a/202608233850406145.html","rn_cache_url":null,"directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://finance.eastmoney.com/a/202608233850406145.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stock_eastmoney","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661248485","title":"全國首屆磁共振腦機接口大會在津舉辦","url":"https://stock-news.laohu8.com/highlight/detail?id=2661248485","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661248485?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 19:17","pubTimestamp":1787483827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217139","title":"聯影、天津大學聯合發布全球首個磁共振腦機接口全棧式解決方案uMR神觀","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217139","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217139?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 12:41","pubTimestamp":1787460101,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/rss/live/live.xml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_gelonghui","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661171362","title":"聯影、天津大學聯合發布全球首個磁共振腦機接口全棧式解決方案uMR神觀","url":"https://stock-news.laohu8.com/highlight/detail?id=2661171362","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661171362?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 12:41","pubTimestamp":1787460076,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217388","title":"Neko Health 與 Neuralink 合作篩選試驗受試者","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217388","media":"链捕手","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217388?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 10:03","pubTimestamp":1787450623,"startTime":"0","endTime":"0","summary":" ChainCatcher 消息，Neko Health 正与脑机接口公司 Neuralink 开展合作，Neko 将协助筛选 Neuralink 下一轮试验的候选受试者。 ","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.chaincatcher.com/article/2284747","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661217889","title":"市場消息：Spotify 首席執行官埃克表示，Neko Health 正與腦機接口公司 Neuralink 開展合作。","url":"https://stock-news.laohu8.com/highlight/detail?id=2661217889","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661217889?lang=zh_tw&edition=fundamental","pubTime":"2026-08-23 09:50","pubTimestamp":1787449827,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["LU2265009873.SGD","IBRN","LU2098885051.SGD","BK4548","LU2360107168.USD","SPOG","MNTL","LU1804176565.USD","LU2250418816.HKD","LU1861220033.SGD","LU2362541273.HKD","LU2362540622.SGD","LU2362541513.USD","BK4571","LU0056508442.USD","LU1303367103.USD","LU1983260115.SGD","BK4108","LU2360106780.USD","LU0786609619.USD","LU1852331112.SGD","BK4585","BK4588","SPOT","LU1861215975.USD","LU2290526834.HKD"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661729986","title":"Scholar Rock撤回了針對肌肉無力藥物的歐洲申報，計劃重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=2661729986","media":"路透中文","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661729986?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 22:48","pubTimestamp":1787323684,"startTime":"0","endTime":"0","summary":"Scholar Rock撤回了针对肌肉无力药物的欧洲申报，计划重新提交路透8月21日-Scholar Rock公司SRRK.O周五表示，已撤回其针对一种实验性脊髓性肌萎缩症药物的欧洲上市申请，并计划在诺和诺德旗下工厂出现问题后，选择其他生产基地重新提交申请NOVOb.CO。Scholar Rock表示，公司已将其美国FDA申请中涉及的印第安纳州生产基地移除，并继续预期监管机构将在9月30日的目标行动日期前作出批准决定。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20260821:nL4T44I0W4:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","SRRK","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661293498","title":"福瑞醫科(300049.SZ)：公司暫無腦機接口的研究","url":"https://stock-news.laohu8.com/highlight/detail?id=2661293498","media":"中金财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661293498?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:17","pubTimestamp":1787318223,"startTime":"0","endTime":"0","summary":"格隆汇8月21日丨福瑞医科(300049.SZ)在投资者互动平台表示，公司暂无脑机接口的研究。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"http://sc.stock.cnfol.com/gushizhibo/20260821/32343226.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"zhongjincaijing_highlight","symbols":["BK0251","BK0028","IBRN","BK0146","300049","BK0096","BK0113","MNTL","BK0114"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1132368667","title":"Scholar Rock控股公司獲日本PMDA認可，無需補充臨床研究；計劃2026年底提交Apitegromab上市申請","url":"https://stock-news.laohu8.com/highlight/detail?id=1132368667","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1132368667?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:12","pubTimestamp":1787317946,"startTime":"0","endTime":"0","summary":"Scholar Rock控股公司迎来重大利好——日本药品和医疗器械管理局（PMDA）已明确表态，认为无需再进行额外的临床研究。这一进展为该公司旗下在研药物Apitegromab的日本上市之路扫清了关键障碍。据此，Scholar Rock计划于2026年底前正式向PMDA提交该药物的上市许可申请（JNDA）。此举标志着公司在全球战略布局中迈出了坚实一步，尤其在亚太核心市场的推进节奏上，展现出明确的执行力与前瞻性。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4139","SRRK","THNR","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1162355391","title":"Scholar Rock Holding公司撤回歐洲上市申請，計劃以替代灌裝生產線重新提交","url":"https://stock-news.laohu8.com/highlight/detail?id=1162355391","media":"美股速递","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1162355391?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:12","pubTimestamp":1787317928,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding Corporation宣布，已主动撤回其药物Apitegromab在欧洲的上市许可申请。这一决定并非基于任何安全性或有效性方面的顾虑，而是源于生产环节中的具体问题。公司表示，将转而采用另一条灌装生产线，并计划在调整完成后重新提交申请。Scholar Rock管理层在声明中表达了对项目前景的信心，并承诺将与欧洲监管机构保持密切沟通，以确保后续流程高效推进。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["SRRK","BK4139","THNR","IBRN"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"1158808120","title":"Scholar Rock Holding Corp：蓄勢待發，靜候FDA批准，Apitegromab擬於2026年9月30日PDUFA日期登陸美國市場","url":"https://stock-news.laohu8.com/highlight/detail?id=1158808120","media":"美股速递","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/1158808120?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 21:10","pubTimestamp":1787317810,"startTime":"0","endTime":"0","summary":"Scholar Rock Holding Corp已经做好全面准备，一旦获得美国食品药品监督管理局的批准，其药物Apitegromab即刻启动在美国市场的上市进程。这一关键节点锁定在2026年9月30日的《处方药使用者付费法案》目标日期。公司上下正厉兵秣马，为这一刻的到来铺平道路。届时，Apitegromab将迅速投放市场，惠及广大患者。这一战略部署彰显了公司对产品获批的坚定信心，也体现了其对市场需求的敏锐把握。随着PDUFA日期的临近，一场精心筹备的市场登陆战即将拉开帷幕。","market":"us","thumbnail":"","type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["IBRN","SRRK","BK4139","THNR"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661260001","title":"深圳落地腦機接口數據知識產權登記","url":"https://stock-news.laohu8.com/highlight/detail?id=2661260001","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661260001?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 20:19","pubTimestamp":1787314755,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["NXTI","PATN","ITAN","IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661252356","title":"佔國內近30%！閔行這裏憑什麼吸引企業和人才？","url":"https://stock-news.laohu8.com/highlight/detail?id=2661252356","media":"滚动播报","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2661252356?lang=zh_tw&edition=fundamental","pubTime":"2026-08-21 13:30","pubTimestamp":1787290200,"startTime":"0","endTime":"0","summary":"依托新虹桥国际医学中心的优质临床禀赋，闵行全域脑机接口创新企业达到60余家，在国内脑机接口产业领域占比近30%，占全市比例六成以上,闵行没有止步于“建载体、引企业”的传统产业培育路径，而是以机制创新破局，探索形成“医-产-研-企”深度协同的产业培育新范式，推动创新资源从简单叠加走向深度融合，让全国首个脑机接口未来产业集聚区持续释放生长动能。闵行坚持“引育并举、生态留才”，让人才与产业同成长、共发展。","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/jjxw/2026-08-21/doc-inipaent8145486.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["IBRN","MNTL"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660470622","title":"山西首例侵入式腦機接口植入術完成 截癱患者有望重塑運動功能","url":"https://stock-news.laohu8.com/highlight/detail?id=2660470622","media":"智通财经","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2660470622?lang=zh_tw&edition=fundamental","pubTime":"2026-08-20 11:17","pubTimestamp":1787195870,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.zhitongcaijing.com/immediately.html?type=usstock","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"live_zhitongcaijing","symbols":["MNTL","IBRN"],"isVideo":false,"video":null,"gpt_icon":0}],"pageSize":20,"totalPage":8,"pageCount":1,"totalSize":155,"code":"91000000","status":"200"}]}}